Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Neuromuscular stimulator enters US trial:

This article was originally published in Clinica

Executive Summary

NeuroControl has begun a multi-centre clinical trial in the US to assess its minimally invasive neuromuscular stimulator for treating shoulder pain in patients who have suffered a stroke. The StIM system is a miniaturised, multi-channel, programmable device designed to reduce shoulder pain and subluxation - the separation of the shoulder joint due to weak muscles. It delivers therapeutic stimulation through electrodes placed in the shoulder muscles. The Cleveland, Ohio based company CE-marked the StIM device for sale in Europe in January (see Clinica No 892, p 25).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT076864

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel